StemGen, Inc.
SGNI
$0.10
$0.06150.00%
| Weiss Ratings | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | -96.00% | |||
| 5-Year Total Return | -87.50% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.10 | |||
| 52-Week Low Price (Date) | Mar 14, 2025 | |||
| 52-Week High Price (Date) | Mar 14, 2025 | |||
| Valuation | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.57M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 47.50% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 250.00 | |||
| Price/Book (Q) | -2.62 | |||
| Enterprise Value/Revenue (TTM) | 268.91 | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | -18.92 | |||
| Enterprise Value/EBIT | -13.44 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 45.67M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 832 954 7569 | |||
| Address | 1 Performance Drive Angleton, TX 77515 | |||
| Website | stemgeninc.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,001.50% | |||
| Profit Margin | -2,683.00% | |||
| Management Effectiveness | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -80.38% | |||
| Return on Equity | -- | |||
| Income Statement | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.00K | |||
| Total Revenue (TTM) | 20.00K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 8.00K | |||
| EBITDA (TTM) | -284.20K | |||
| EBIT (TTM) | -400.30K | |||
| Net Income (TTM) | -536.60K | |||
| Net Income Avl. to Common (TTM) | -536.60K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -89.21% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | -86.36% | |||
| Balance Sheet | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 22.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 22.90K | |||
| Total Preferred Equity (Q) | 0.01 | |||
| Total Equity (Q) | -1.74M | |||
| Current Ratio (Q) | 0.012 | |||
| Book Value Per Share (Q) | -$0.04 | |||
| Total Assets (Q) | 140.40K | |||
| Total Current Liabilities (Q) | 1.88M | |||
| Total Debt (Q) | 828.00K | |||
| Total Liabilities (Q) | 1.88M | |||
| Total Common Equity (Q) | -1.74M | |||
| Cash Flow | SGNI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 255.00K | |||
| Cash from Financing (TTM) | 16.80K | |||
| Net Change in Cash (TTM) | 12.00K | |||
| Levered Free Cash Flow (TTM) | -33.90K | |||
| Cash from Operations (TTM) | -259.70K | |||
